Medical News

RSS

ResCare chooses GuardianEdge to assist in HIPAA compliance

GuardianEdge, the leader in endpoint data protection, today announced that ResCare, one of the nation's leading providers of services to people with disabilities and the elderly, has selected GuardianEdge to secure the company's more than 6,000 endpoint devices and to assist in Health Insurance Portability and Accountability Act (HIPAA) compliance. To ensure that sensitive patient data is secure, ResCare has deployed GuardianEdge Hard Disk Encryption, GuardianEdge Removable Storage Encryption and GuardianEdge Device Control.

21 Jan 2010

MDRNA to receive European patent for its intranasal insulin formulation

MDRNA, Inc., a leading RNAi-based drug discovery and development company, today announced that the European Patent Office intends to grant a patent for application EP06826368 covering formulations for the intranasal delivery of rapid acting insulin, and its use for the treatment of diabetes.

21 Jan 2010

CPRIT awards the first $61M in grants for cancer research

The Cancer Prevention and Research Institute of Texas (CPRIT) awarded on January 20th the first $61 million in grants for cancer research projects at academic institutions and private companies throughout Texas. These are the inaugural grants of the $3 billion to be invested in cancer research in Texas over the next ten years.

21 Jan 2010

Phase Forward releases Empirica Signal version 7.2 signal detection and management software

Phase Forward, a leading provider of data solutions for clinical trials and drug safety, today announced the availability of version 7.2 of its Empirica™ Signal product, a significant new release of the company’s flagship signal detection and management software. The Empirica Signal solution is a state-of-the-art data mining and knowledge management tool and a cornerstone component of Phase Forward’s Empirica Suite of pharmacovigilance and risk management products.

21 Jan 2010

Ipsen and Inspiration Biopharmaceuticals form strategic partnership

Celtic Pharmaceutical Holdings L.P. ("Celtic Pharma") today announced the formation of a strategic partnership between Ipsen and Inspiration Biopharmaceuticals ("Inspiration") to create a world leading hemophilia franchise, an important milestone for the Celtic Pharma portfolio.

21 Jan 2010

Symbollon Pharmaceuticals to launch IoGen women's breast health dietary supplement in February

Symbollon Pharmaceuticals, Inc. has announced today that the retail launch of IoGen™, its dietary supplement for women's breast health, will commence in February. IoGen™ is the first dietary supplement formulated to promote breast health for women. Initially, the Company plans to market IoGen™ through its own retail web site, which is currently being developed by Atech Solutions.

21 Jan 2010

Amgen announces results of two Phase 3 studies evaluating Vectibix for mCRC

Amgen today announced that detailed results from two pivotal Phase 3 studies evaluating Vectibix® (panitumumab) in combination with chemotherapy for the first and second-line treatment of metastatic colorectal cancer (mCRC) (the PRIME '203' and '181' trials, respectively) will be presented at the 2010 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium in Orlando, Florida from Jan. 22-24, 2010.

21 Jan 2010

Rules for patient data security remain widely unenforced

"As the federal government prepares to spend up to $27 billion in stimulus funds to promote electronic medical records, a health technology industry survey suggests that a number of hospitals, health clinics, and insurance firms are violating federal security rules on patient data and putting sensitive health information at risk," The Center for Public Integrity reports.

21 Jan 2010

Genomic Health announces global commercial availability of its Oncotype DX colon cancer test

Genomic Health, Inc. today announced worldwide commercial availability of its Oncotype DX® colon cancer test, the first multigene expression test developed for the assessment of risk of recurrence in patients with stage II disease. The 12-gene advanced diagnostic test is clinically validated to predict individual recurrence risk in stage II colon cancer patients following surgery, as reported at the 2009 American Society of Clinical Oncology (ASCO) meeting.

21 Jan 2010

China Pharma Holdings announces completion of clinical trials for Candesartan

China Pharma Holdings, Inc., which develops, manufactures, and markets specialty pharmaceutical products in China, today announced that the Company has completed clinical trials for Candesartan, an anti-hypertension drug, and submitted the generic drug production application to the SFDA.

21 Jan 2010

Health IT news: Grassley queries hospitals, Microsoft's CEO sees need to boost tech for doctors, hospitals

Modern Healthcare: "Sen. Chuck Grassley (R-Iowa) has sent a letter asking 31 hospitals to report on their relationships with healthcare IT vendors, focusing on errors caused by IT systems and on so-called 'gag order or non-disclosure clauses' in vendor contracts that might prohibit the hospitals from disclosing information about system flaws." Grassley made a similar request to the IT vendors themselves last fall, and said his new letter was prompted by concern about taxpayers' investment in health IT as part of the economic stimulus (Conn, 1/20).

21 Jan 2010

PhotoMedex regains compliance with Nasdaq minimum bid price requirement

PhotoMedex, Inc. today announced that it has regained compliance with the minimum bid price requirement of The Nasdaq Stock Market under Nasdaq Listing Rule 5450(a)(1).

21 Jan 2010

Health care companies assess where they stand on health reform after election

The Wall Street Journal reports that several firms reiterated support for a health care reform bill Wednesday, a day after the overhaul's viability was called into question by the victory of Republican Sen.-elect Scott Brown in Massachusetts. "PhRMA, the drug industry association, as well as companies including Pfizer Inc., Johnson & Johnson, WellPoint Inc. and Humana Inc., voiced support for an overhaul of some kind, despite objections among insurers about the efforts to date."

21 Jan 2010

Fourth-quarter and fiscal year 2009 results announced by Somanetics

Somanetics Corporation today reported financial results for the fourth fiscal quarter and year ended November 30, 2009.

21 Jan 2010

Zirmed achieves EHNAC HNAP accreditation

ZirMed®, a leading national provider of revenue cycle management solutions for healthcare providers, announced yesterday it has achieved full accreditation with the Healthcare Network Accreditation Program (HNAP) from the Electronic Healthcare Network Accreditation Commission (EHNAC). EHNAC's HNAP accreditation recognizes excellence in health data processing and transactions, and indicates compliance with industry-established standards and HIPAA regulations.

21 Jan 2010

Neuralstem announces treatment of first ALS patient with spinal cord stem cells

Neuralstem, Inc. announced that the first ALS patient was treated with its spinal cord stem cells yesterday at the Emory ALS Center at Emory University, in Atlanta, GA. A total of up to 18 patients is planned to be treated in this first U.S. clinical trial to evaluate human neural stem cells for the treatment of ALS (Amyotrophic Lateral Sclerosis, or Lou Gehrig's disease). ALS affects roughly 30,000 people in the U.S., with about 5,600 new diagnoses per year, according to the ALS Association.

21 Jan 2010

Elevation Pharmaceuticals closes $30M tranched Series A financing

Elevation Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of new aerosol therapies for patients with respiratory diseases, announced today the closing of a $30 million tranched Series A financing.

21 Jan 2010

Enrollment complete in Vertos Medical's U.S. IRB I "mild" procedure Patient Outcomes Trial

Medical device company Vertos Medical Inc. has announced the completion of enrollment in its post-market U.S. IRB (Institutional Review Board) I Patient Outcomes Trial, a 75-patient study of the mild procedure. The open-label, single-arm, prospective, IRB-approved study is intended to gather patient outcomes data following treatment for symptomatic central canal spinal stenosis using proprietary mild devices. Results from the trial, which is being conducted by 14 investigators at academic and private practice settings across the United States, are expected to be published during 2010.

21 Jan 2010

Charterhouse Group announces definitive agreement to sell Amerifit Brands to Martek Biosciences

Charterhouse Group, Inc. ("Charterhouse") today announced a definitive agreement to sell Amerifit Brands, Inc. ("Amerifit" or the "Company"), a leading consumer health and wellness company, to Martek Biosciences Corporation ("Martek") in a transaction valued at $200 million.

21 Jan 2010

Applied Biosystems' AmpFℓSTR MiniFiler PCR Amplification Kit receives NDIS approval

Applied Biosystems, part of Life Technologies Corporation today announced that its AmpFℓSTR® MiniFiler™ PCR Amplification Kit has been approved for inclusion in the National DNA Index System (NDIS), a United States Federal Bureau of Investigation database that facilitates the electronic comparison and exchange of DNA profiles between participating local, county, state, and federal law enforcement agencies and forensic laboratories.

21 Jan 2010

Medical News

ResCare chooses GuardianEdge to assist in HIPAA compliance

MDRNA to receive European patent for its intranasal insulin formulation

CPRIT awards the first $61M in grants for cancer research

Phase Forward releases Empirica Signal version 7.2 signal detection and management software

Ipsen and Inspiration Biopharmaceuticals form strategic partnership

Symbollon Pharmaceuticals to launch IoGen women's breast health dietary supplement in February

Amgen announces results of two Phase 3 studies evaluating Vectibix for mCRC

Rules for patient data security remain widely unenforced

Genomic Health announces global commercial availability of its Oncotype DX colon cancer test

China Pharma Holdings announces completion of clinical trials for Candesartan

Health IT news: Grassley queries hospitals, Microsoft's CEO sees need to boost tech for doctors, hospitals

PhotoMedex regains compliance with Nasdaq minimum bid price requirement

Health care companies assess where they stand on health reform after election

Fourth-quarter and fiscal year 2009 results announced by Somanetics

Zirmed achieves EHNAC HNAP accreditation

Neuralstem announces treatment of first ALS patient with spinal cord stem cells

Elevation Pharmaceuticals closes $30M tranched Series A financing

Enrollment complete in Vertos Medical's U.S. IRB I "mild" procedure Patient Outcomes Trial

Charterhouse Group announces definitive agreement to sell Amerifit Brands to Martek Biosciences

Applied Biosystems' AmpFℓSTR MiniFiler PCR Amplification Kit receives NDIS approval

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Latest News